93 related articles for article (PubMed ID: 11391602)
1. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
[TBL] [Abstract][Full Text] [Related]
2. DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy.
Pukl M; George M; Javanmardi A; Carraro A; Korbelik J; White R; MacAulay C; Palcic B; Keyes M; Volavšek M; Guillaud M
Urol J; 2024 Mar; 21(2):80-86. PubMed ID: 37481706
[TBL] [Abstract][Full Text] [Related]
3. Tumour heterogeneity poses a significant challenge to cancer biomarker research.
Cyll K; Ersvær E; Vlatkovic L; Pradhan M; Kildal W; Avranden Kjær M; Kleppe A; Hveem TS; Carlsen B; Gill S; Löffeler S; Haug ES; Wæhre H; Sooriakumaran P; Danielsen HE
Br J Cancer; 2017 Jul; 117(3):367-375. PubMed ID: 28618431
[TBL] [Abstract][Full Text] [Related]
4. 3D-Reconstructed Contact Surface Area and Tumour Volume on Magnetic Resonance Imaging Improve the Prediction of Extraprostatic Extension of Prostate Cancer.
Veerman H; Hoeks CMA; Sluijter JH; van der Eijk JA; Boellaard TN; Roeleveld TA; van der Sluis TM; Nieuwenhuijzen JA; Wit E; Rijkhorst EJ; Heymans MW; van Alphen MJA; van Veen RLP; Vis AN; van der Poel HG; van Leeuwen PJ
J Digit Imaging; 2023 Apr; 36(2):486-496. PubMed ID: 36547859
[TBL] [Abstract][Full Text] [Related]
5. Urinary nerve growth factor as an oncologic biomarker for prostate cancer aggressiveness.
Liss MA; Gordon A; Morales B; Osann K; Skarecky D; Lusch A; Zaldivar F; Ahlering TE
Urol Oncol; 2014 Jul; 32(5):714-9. PubMed ID: 24794250
[TBL] [Abstract][Full Text] [Related]
6. Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasets.
Berney DM; Finnegan K; Chu K; Fine SW; Varma M; Cuzick J; Beltran L;
Histopathology; 2023 Jun; 82(7):1021-1028. PubMed ID: 36779238
[TBL] [Abstract][Full Text] [Related]
7. Outlook of Gleason score in prostate carcinoma and correlation with PSA levels: A study in a tertiary care hospital.
Rani E; Nibhoria S; Nagpal N
J Cancer Res Ther; 2023; 19(5):1305-1310. PubMed ID: 37787299
[TBL] [Abstract][Full Text] [Related]
8. Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer.
Muller BG; Swaan A; de Bruin DM; van den Bos W; Schreurs AW; Faber DJ; Zwartkruis EC; Rozendaal L; Vis AN; Nieuwenhuijzen JA; van Moorselaar RJ; van Leeuwen TG; de la Rosette JJ
Technol Cancer Res Treat; 2017 Feb; 16(1):57-65. PubMed ID: 26818025
[TBL] [Abstract][Full Text] [Related]
9. Pathology Data-Based Risk Group Stratification Is Equivalent to That Obtained by Oncotype DX Testing in Prostatic Adenocarcinoma.
Renavikar PS; LaGrange CA; Lele SM
Arch Pathol Lab Med; 2023 Oct; 147(10):1158-1163. PubMed ID: 36596267
[TBL] [Abstract][Full Text] [Related]
10. The Value of Combined Detection of Serum PSA, MALAT1 and TMPRSS2-ETV1 in Evaluating the Progress and Prognosis of Prostate Cancer.
Zhao G; Pan Z; Wang P
Arch Esp Urol; 2023 Oct; 76(8):555-562. PubMed ID: 37960954
[TBL] [Abstract][Full Text] [Related]
11. Topline/Final Diagnostic Inclusion of Relevant Histologic Findings in Surgical Pathology Reporting of Carcinoma in Prostate Biopsies.
Mullane P; Williamson SR; ; Sangoi AR
Int J Surg Pathol; 2024 Mar; ():10668969241231972. PubMed ID: 38504649
[TBL] [Abstract][Full Text] [Related]
12. A Study of Ki-67 Immunostaining in Prostate Carcinomas and Its Correlation with Gleason's Score and Prognosis: An Experience at a Tertiary Centre in the Himalayan Foothills.
Jha N; Phulware RH; Kumar A; Singh A; Durgapal P; Chowdhury N; Mittal A; Kishore S
Indian J Surg Oncol; 2024 Jun; 15(2):341-348. PubMed ID: 38741642
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens.
Tadayyon F; Mellat M; Alizadeh F; Hadi M; Khorrami M; Yazdani M; Joozdani RH
Adv Biomed Res; 2013; 2():3. PubMed ID: 23930248
[TBL] [Abstract][Full Text] [Related]
14. scAbsolute: measuring single-cell ploidy and replication status.
Schneider MP; Cullen AE; Pangonyte J; Skelton J; Major H; Van Oudenhove E; Garcia MJ; Chaves Urbano B; Piskorz AM; Brenton JD; Macintyre G; Markowetz F
Genome Biol; 2024 Mar; 25(1):62. PubMed ID: 38438920
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the origin and invasion of prostate cancer from autopsy and radical prostatectomy specimens.
Mai Z; Yuan R; Yan W; Zhou Y; Zhou Z; Ren M; Xiao Y; Huang H; Huang Y
Transl Cancer Res; 2024 Feb; 13(2):651-660. PubMed ID: 38482427
[TBL] [Abstract][Full Text] [Related]
16. The significance of perineural invasion found on needle biopsy of the prostate: implications for definitive therapy.
Potter SR; Partin AW
Rev Urol; 2000; 2(2):87-90. PubMed ID: 16985741
[No Abstract] [Full Text] [Related]
17. Failure of Ploidy and Proliferative Fraction to Predict Long-Term Outcome After Prostatectomy.
Swanson GP; Chen W; Speights VO
World J Oncol; 2018 Jun; 9(3):69-73. PubMed ID: 29988804
[TBL] [Abstract][Full Text] [Related]
18. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
[TBL] [Abstract][Full Text] [Related]
19. [Molecular biomarkers and prognostic factors for prostate cancer].
Kretschmer A; Tolkach Y; Ellinger J; Kristiansen G
Urologe A; 2017 Jul; 56(7):933-944. PubMed ID: 28573413
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Perineural Invasion in Prostate Needle Biopsy Specimens and Pathologic Staging After Radical Prostatectomy.
Niroomand H; Nowroozi M; Ayati M; Jamshidian H; Arbab A; Momeni SA; Ghadian A; Ghorbani H
Nephrourol Mon; 2016 May; 8(3):e36022. PubMed ID: 27635390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
